Randomized trials of dietary antioxidants in cardiovascular disease prevention and treatment

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 3, Issue 4, 1996, Pages 368-371

  Gaziano, J Michael ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

antioxidants; atherosclerosis; cardiovascular disease; coronary heart disease; vitamin E; carotene

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; RETINOL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; HUMANS; PROGNOSIS;

EID: 0029959529     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182679600300406     Document Type: Article

References (19)

1. Hennekens CH, Buring JE: Epidemiology in Medicine. Boston: Little Brown; 1987.
2. Hennekens CH, Buring JE: Observational evidence Ann NY Acad Sci 1994, 703: 18–24.
3. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ etal: Nutrition intervention trials in Lixian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population J Natl Cancer Inst 1993, 85: 1483–1492. Thefirst large-scale randomized trial of vitamins in the prevention of cancer conducted among a poorly-nourished population in Linxian, People's Republic of China. Findings include a reduction in overall mortality among those consuming a mixture of β-carotene (15 mg/day), α-tocopherol (30mg/day) and selenium (50μg/day) that was largely due to a reduction in stomach cancer mortality.
4. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 1994, 330: 1029–1035. The ATBC Trial is the first large-scale randomized trial of antioxidant vitamins in a well-nourished population. This 2×2 factorial trial tested the effect of synthetic α-tocopherol (50 mg/day) and synthetic β-carotene (20 mg/day) in the prevention of lung cancer among 29 133 Finnish male smokers.
5. Rapola JM, Virtamo J, Haukka JK, Heinonen OP, Albanes D, Taylor PR etal: Effect of vitamin E and beta carotene on the incidence of angina pectoris: A randomized double-blind, controlled trial JAMA 1996, 275: 693–698.
6. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC: A prospective study of vitamin E consumption and risk of coronary disease in women N Engl J Med 1993, 328: 1444–1449.
7. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC: Dietary intake and risk of coronary heart disease among men N Engl J Med 1993, 328: 1450–1456.
8. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR etal: Lack of effect of long term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N Engl J Med 1996, 334: 1145–1149. The PHS is a randomized, double-blind, placebo-controlled trial of β-carotene (50 mg on alternate days) among 22071 healthy, well-nourished, male physicians in the USA, aged 40–84 years. This large-scale randomized trial among apparently healthy well-nourished men provides substantial evidence that 12 years of β-carotene supplementation causes neither benefit nor harm in terms of cardiovascular disease mortality or malignant neoplasms.
9. Omenn GS, Goodman GE, Thomquist MD, Blames JD, Cullen MR, Glass A etal: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease N Engl J Med 1996, 334: 1150–1155. The Beta Carotene and Retinol Efficacy Trial (CARET) among 18314 men and women at high risk of lung cancer caused by a history of cigarette smoking or occupational exposure to asbestos, or both, evaluated a combined treatment of β-carotene (30 mg/day) and retinol (25000 IU/day).
10. Greenberg ER, Baron JA, Karagas MR, Stukel TA, Nierenberg DW, Stevens MM etal: Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation JAMA 1996, 275: 660–703.
11. Livingston PD, Jones C: Treatment of intermittent claudication with vitamin E Lancet 1958, ii: 602–604.
12. Williams HTG, Fenna D, MacBeth RA: Alpha tocopherol in the treatment of intermittent claudication Surg Gynecol Obstet 1971, 132: 662–666.
13. Haeger K: Long term treatment of intermittent claudication with vitamin E Am J Clin Nutr 1974, 27: 1179–1181.
14. Anderson TW, Reid W: A double-blind trial of vitamin E in the treatment of angina pectoris Am Heart J 1974, 93: 444–449.
15. Gillian RE, Mandell B, Warbasse JR: Quantitative evaluation of vitamin E in the treatment of angina pectoris Am Heart J 1977, 93: 444–449.
16. DeMaio SJ, King SB III, Lembo NJ, Roubin GS, Hearn JA, Bhagavan HN etal: Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA) J Am Coll Nutr 1992, 11: 131–138.
17. Gaziano JM, Manson JE, Ridker PM, Buring JE, Hennekens CH: Beta carotene therapy for chronic stable angina Circulation 1990, 82 (suppl III):III202.
18. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman Mitchinson MJ etal: Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet 1996, 347: 781–786.
19. Hennekens CH, Buring JE, Peto R: Antioxidant vitamins — benefits not yet proven N Engl J Med 1994, 330: 1080–1081.